August 2011
Gerolymatos International and Ferrer join forces to launch Sinomarin®
in various markets in North Africa and the Middle East
Gerolymatos International, a leading Greek multinational, OTC
pharmaceutical and cosmetics company, has granted Ferrer, one of the
top Spanish R&D-based pharmaceutical companies, the exclusive
distribution rights to market Sinomarin®, a hypertonic sea water
family of products, in Algeria, Morocco, Iraq, Pakistan and Malta.
This collaboration reinforces Gerolymatos International’s global
presence with Sinomarin® and complements Ferrer’s portfolio, worldwide
distribution network and international profile. This strategic
alliance is expected to generate a significant turnover for both
companies in the next few years.
Sinomarin® is a hypertonic seawater solution used for the decongestion
and cleansing of nasal cavities that was initially developed and
marketed in France, but soon expanded to 36 countries globally,
including USA, Canada, Central and South America, Europe, Asia and
Africa. The seawater is derived from a fully-owned seawater source at
Cancale, near Saint Malo, France and is manufactured at Gerolymatos
International's facilities located in Athens, Greece. Sinomarin® is a
CE-Mark-bearing medical device and holds a patent in a number of key
territories. It is a cohesive family of hypertonic products comprising
an adult spray, a children’s spray, a mini spray and monodose vials
for infants and toddlers. Additional products are currently being
developed to further expand the existing Sinomarin® brand within the
next few months.
Gerolymatos International S.A. has been associated with the health
care and beauty industry since 1923 when the founder opened a pharmacy
in the centre of Athens. The company swiftly grew in size and began
its export activities in the 1970s and since then, it has continuously
expanded its international network to over 50 countries through
partnerships and affiliates across the five continents. Today,
Gerolymatos International is a major global player in the field of
natural seawater-based products such as Sinomarin® and a well
established player in OTC pharmaceutical products.
Ferrer was founded in 1959 and is a privately-held Spanish
pharmaceutical company, fully integrated from R&D to distribution. It
is present in more than 90 countries and has 23 international
affiliates. Ferrer is active in the pharmaceutical, health, fine
chemicals and food sectors, key areas for contributing to people’s
health and quality of life. Since the beginning, Ferrer has been
committed to the research and development of innovative medicinal
products in its six R&D centres and to a solid industrial structure,
with thirteen manufacturing centers. In recent years, it has
concentrated on diversifying across the whole healthcare spectrum and
setting-up and consolidating strategic alliances. The result has been
a significant globalization of its activities, backed up by an
efficient management of regulatory affairs, with more than 1300 active
registrations worldwide.
